SOX14 presented hypermethylation in cervical cancers; furthermore, with the optimal cut-off value, the sensitivity and specificity in the differentiation of precancer and cancer were 94.12 and 86.46%, respectively. This evidence concerns the gene SOX14 and cervical cancer.